Author： Gupta A.K.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.22, Iss.1, 2000-01, pp. : 33-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
A Risk-Benefit Assessment of Drugs Used for Neonatal Chronic Lung Disease
Drug Safety, Vol. 22, Iss. 5, 2000-05 ,pp. :
A Benefit-Risk Assessment of Agents Used in the Secondary Prevention of Stroke
By MacWalter R.S. Shirley C.P.
Drug Safety, Vol. 25, Iss. 13, 2002-01 ,pp. :
A Risk-Benefit Assessment of Abciximab in Angioplasty
By Kleiman N.S.
Drug Safety, Vol. 20, Iss. 1, 1999-01 ,pp. :
A Risk-Benefit Assessment of Amifostine in Cytoprotection
By Mabro M.
Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. :